Renowned Retraction

Authors retract a decade-old, highly-cited cancer study, admitting sloppy mistakes in the data analysis.

Written byBeth Marie Mole
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

MIT Building 10 and the Great Dome, Cambridge MassachusettsWIKIMEDIA, JOHN PHELANA leading cancer researcher at the Massachusetts Institute of Technology, Robert Weinberg, has retracted a study published in 2003 in Cancer Cell—which has been cited 233 times, according to ISI Web of Knowledge—upon realizing that the study contained careless errors. The authors claim that the retraction is not meant to negate the conclusions of the study, rather it’s meant to purge the literature of the inaccurate data presentation, according to a notice they published on the journal’s website.

“Although we stand by the conclusions of the paper and intend to provide support for them in future publications, the inappropriate presentation did not and does not fall within the bounds of acceptable scienti?c practice,” the authors wrote in the notice. “Accordingly, we are retracting the paper in its entirety.”

The statement also noted that one of the original authors, Yi-Ning Cheng, could not be reached regarding the retraction.

In a statement provided to Retraction Watch, Weinberg elaborated on the publication’s errors, emphasizing that they were not due to misconduct. “These errors occurred during the (electronic) assembly of the figures, with internal loading controls being misassembled with the incorrect experimental channels,” Weinberg said. “There was not and is not any indication of scientific misconduct, simply ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies